Based on our advanced algorithm, we predict that IPHA stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $1.94, while the 1-week outlook suggests a value of $2.02. For the 1-month forecast, we project a price of $1.95. Looking further ahead, our 2026 projection estimates a value of $0.00, with a long-term 2030 forecast reaching $0.00. Stay informed and make strategic decisions with our data-driven insights!
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. IPHA has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
IPHA stock price ended at $1.91 on Thursday, after rising0.53%
The Innate Pharma SA stock price increased by 0.53% on the last trading day (04 Dec 2025), rising from 1.89 to 1.91. Throughout the last trading session, the stock experienced a fluctuation of 3.17% , ranging from a day low of $1.89 to a day high of 1.95. The price has declined in 3 of the last 10 days, resulting in a total change of 6.70% during this period. On the last day, trading volume decrease by -24.03K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 3.49K shares were traded, amounting to approximately 6.77K.
IPHA Technical Signals
IPHA(Innate Pharma SA Corp) has 1 buy signal and 3 sell signals now. The current trend is an uptrend starting from 2025-11-18. The total price change during this trend is +6.11%. Recently, the price has increased while volume droped, indicating a potential warning signal. The average turnover of IPHA over the last 5 trading days is 36.50K. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.
IPHA Moving Average Analysis
Innate Pharma SA's overall moving average trend leans more bearish as of Friday, December 5, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $2.03, and $2.12. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $1.75, and $1.66. A break-down below any of these levels will issue sell signals.
IPHA Short Selling Analysis
The short sale ratio of Innate Pharma SA(IPHA) as of 03 Dec 2025 is 29.75%, rising from last trading day. With increasing price from 1.95 to 1.90. The short sell activity indicate that short sellers may be anticipating further declines.
Technical Signal
Technical Signals Summary
Sell
3
Buy
1
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
1 Bullish Signals
1 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Momentum (10 days)
MOM_10 > 0
0.12
Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
In 2026, Innate Pharma SA (IPHA) is anticipated to change hands in a trading channel between $0.00 and $0.00.
Innate Pharma SA Stock Forecast 2026
IPHA Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Innate Pharma SA(IPHA), our algorithm predicts IPHA's 1-month price at $1.90, with an -2.4%downwardshift. Using a similarity score up to 91.94%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Innate Pharma SA (IPHA.O) stock, as of Sunday, November 30, 2025 , forecasts a -2.4% change over the next month, based on its high correlation with FRST.O stock patterns. The similarity between their price movements over the analyzed periods is 91.94%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
IPHA
No Data
FRST
Down: -2.4%Similarity: 91.94%
Name
Similarity
Up/Down
FRST.O
91.94%
-2.40%
QNTM.O
91.34%
-20.94%
BRFH.O
91.26%
0.00%
GNK.N
91.12%
+12.73%
IPHA Seasonality Analysis
Based on IPHA's historical stock price data across all years, the probability of a positive return in December is57.14%, suggesting it maybe an ideal month to invest in IPHA. In contrast,Julyoffers the highest probability of positive returns at66.67%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Innate Pharma SA (IPHA.O) stock in July has the highest probability of a positive return (66.67%), while January has the lowest probability (16.67%).
Performance Seasonality
The chart shows Innate Pharma SA. (IPHA)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Innate Pharma SA (IPHA.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. IPHA has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Innate Pharma SA (IPHA.O) stock in a year?
The radar chart shows that buying Innate Pharma SA (IPHA.O) stock in July has the highest probability of a positive return (66.67%), while January has the lowest probability (16.67%).
How has Innate Pharma SA. (IPHA)'s stock price performed over the past three years?
IPHA's stock price fell by -17.65% in 2023,decreased by -32.35% in 2024, and went up by 2.14%in 2025.
Which bullish technical signals does IPHA have?
Bullish technical signals of IPHA include: MOM_10 > 0.
Is IPHA a buy based on overall technical signals summary?
IPHA has 1 buy signals and 3 sell signals now. Overall the technical rating for IPHA is Sell . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of IPHA.
What is the trend of Innate Pharma SA (IPHA)'s moving average?
Innate Pharma SA's overall moving average trend leans more bearish as of December 05 2025, with 3 negative signals and 1 positive signal.
What is price prediction for IPHA stock next month?
The price prediction chart for Innate Pharma SA (IPHA.O) stock, as of November 30 2025, forecasts a -2.4% change over the next month, based on its high correlation with FRST stock patterns. The similarity between their price movements over the analyzed periods is 91.94%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2026 for Innate Pharma SA (IPHA) Stock?
In , Innate Pharma SA's value is forecasted to reach an average price of $NaN. The price is predicted to fluctuate between a low of $NaN and a high of $NaN.
What is price prediction 2030 for Innate Pharma SA (IPHA) Stock?
In , Innate Pharma SA's value is forecasted to reach an average price of $NaN. The price is predicted to fluctuate between a low of $NaN and a high of $NaN.